14-day Premium Trial Subscription Try For FreeTry Free
$0.0008
+0 (+0%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0007 $0.0026 Thursday, 2nd May 2024 PPCB stock ended at $0.0008. During the day the stock fluctuated 28.57% from a day low at $0.0007 to a day high of $0.0009.
90 days $0.0007 $0.0065
52 weeks $0.0001 $0.263

Historical Propanc Biopharma Inc prices

Date Open High Low Close Volume
Dec 07, 2023 $0.0110 $0.0185 $0.0097 $0.0115 2 711 661
Dec 06, 2023 $0.0077 $0.0129 $0.0073 $0.0105 3 447 328
Dec 05, 2023 $0.0075 $0.0085 $0.0072 $0.0075 896 977
Dec 04, 2023 $0.0089 $0.0089 $0.0077 $0.0085 127 843
Dec 01, 2023 $0.0080 $0.0093 $0.0078 $0.0083 934 977
Nov 30, 2023 $0.0086 $0.0088 $0.0075 $0.0085 960 449
Nov 29, 2023 $0.0094 $0.0094 $0.0083 $0.0083 551 871
Nov 28, 2023 $0.0095 $0.0098 $0.0081 $0.0097 725 625
Nov 27, 2023 $0.0091 $0.0100 $0.0091 $0.0099 62 004
Nov 24, 2023 $0.0094 $0.0098 $0.0090 $0.0098 33 123
Nov 22, 2023 $0.0096 $0.0098 $0.0092 $0.0098 319 446
Nov 21, 2023 $0.0100 $0.0109 $0.0093 $0.0109 972 873
Nov 20, 2023 $0.0101 $0.0120 $0.0092 $0.0112 562 606
Nov 17, 2023 $0.0109 $0.0126 $0.0106 $0.0120 465 874
Nov 16, 2023 $0.0135 $0.0136 $0.0100 $0.0123 183 703
Nov 15, 2023 $0.0155 $0.0177 $0.0122 $0.0133 87 396
Nov 14, 2023 $0.0108 $0.0210 $0.0096 $0.0146 448 594
Nov 13, 2023 $0.0101 $0.0119 $0.0089 $0.0109 1 023 932
Nov 10, 2023 $0.0120 $0.0127 $0.0106 $0.0110 208 918
Nov 09, 2023 $0.0138 $0.0138 $0.0100 $0.0100 420 757
Nov 08, 2023 $0.0190 $0.0190 $0.0138 $0.0143 450 484
Nov 07, 2023 $0.0133 $0.0205 $0.0125 $0.0190 708 622
Nov 06, 2023 $0.0102 $0.0126 $0.0090 $0.0126 1 855 795
Nov 03, 2023 $0.0120 $0.0125 $0.0099 $0.0120 814 224
Nov 02, 2023 $0.0104 $0.0125 $0.0085 $0.0120 958 539
Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT